BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35910795)

  • 21. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
    Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
    Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Gold Nanorods Conjugated with Radiolabeled Anti-human Epidermal Growth Factor Receptor 2 (HER2) Monoclonal Antibody as Single-Photon Emission Computed Tomography/Photoacoustic Dual-Imaging Probes Targeting HER2-Positive Tumors.
    Ding N; Sano K; Shimizu Y; Watanabe H; Namita T; Shiina T; Ono M; Saji H
    Biol Pharm Bull; 2020; 43(12):1859-1866. PubMed ID: 33268703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A liposomal radionanoformulation for targeted drug delivery and real time monitoring by radionuclide imaging for HER2 overexpressing cancers.
    Suman SK; Mukherjee A; Sharma RK
    Drug Dev Res; 2023 Nov; 84(7):1553-1563. PubMed ID: 37578143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
    Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
    J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and
    Okarvi SM; Aljammaz I
    Anticancer Res; 2018 May; 38(5):2823-2830. PubMed ID: 29715105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a
    Zhao L; Liu C; Xing Y; He J; O'Doherty J; Huang W; Zhao J
    Mol Pharm; 2021 Sep; 18(9):3616-3622. PubMed ID: 34328338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by
    Wimana Z; Gebhart G; Guiot T; Vanderlinden B; Larsimont D; Doumont G; Van Simaeys G; Goldman S; Flamen P; Ghanem G
    Oncotarget; 2017 Aug; 8(34):56185-56198. PubMed ID: 28915583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non-Small Cell Lung Cancer.
    Han Z; Xiao Y; Wang K; Yan J; Xiao Z; Fang F; Jin Z; Liu Y; Sun X; Shen B
    J Nucl Med; 2018 Nov; 59(11):1686-1691. PubMed ID: 29777004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging.
    Zhu X; Li J; Hong Y; Kimura RH; Ma X; Liu H; Qin C; Hu X; Hayes TR; Benny P; Gambhir SS; Cheng Z
    Mol Pharm; 2014 Apr; 11(4):1208-17. PubMed ID: 24524409
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Rainone P; De Palma A; Sudati F; Roffia V; Rigamonti V; Salvioni L; Colombo M; Ripamonti M; Spinelli AE; Mazza D; Mauri P; Moresco RM; Prosperi D; Belloli S
    Int J Nanomedicine; 2021; 16():1943-1960. PubMed ID: 33727808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
    Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
    Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I Trial of
    Bragina O; Chernov V; Schulga A; Konovalova E; Garbukov E; Vorobyeva A; Orlova A; Tashireva L; Sörensen J; Zelchan R; Medvedeva A; Deyev S; Tolmachev V
    J Nucl Med; 2022 Apr; 63(4):528-535. PubMed ID: 34385343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging of Integrin α
    Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE
    Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive Imaging of Tumor PD-L1 Expression Using [
    Zhang Y; Ding Y; Li N; Wang S; Zhou S; Li R; Yang H; Li W; Qu J
    Mol Pharm; 2023 Jan; 20(1):690-700. PubMed ID: 36541699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Integrin Alpha 6-Targeted Radiotracer with Improved Receptor Binding Affinity and Tumor Uptake.
    Luo Q; Yang G; Gao H; Wang Y; Luo C; Ma X; Gao Y; Li X; Zhao H; Jia B; Shi J; Wang F
    Bioconjug Chem; 2020 May; 31(5):1510-1521. PubMed ID: 32347718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-resolution single-photon emission computed tomography and X-ray computed tomography imaging of Tc-99m-labeled anti-DR5 antibody in breast tumor xenografts.
    Kim H; Chaudhuri TR; Buchsbaum DJ; Wang D; Zinn KR
    Mol Cancer Ther; 2007 Mar; 6(3):866-75. PubMed ID: 17363481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
    McLarty K; Cornelissen B; Cai Z; Scollard DA; Costantini DL; Done SJ; Reilly RM
    J Nucl Med; 2009 Aug; 50(8):1340-8. PubMed ID: 19617342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and Biological Evaluation of Novel
    Song X; Gan Q; Zhang X; Zhang J
    Mol Pharm; 2019 Oct; 16(10):4213-4222. PubMed ID: 31424939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-Modality PET-SPECT Image-Guided Pretargeting Delivery in HER2(+) Breast Cancer Models.
    Hapuarachchige S; Si G; Huang CT; Lesniak WG; Mease RC; Guo X; Gabrielson K; Artemov D
    Biomacromolecules; 2021 Nov; 22(11):4606-4617. PubMed ID: 34704434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.